---
category: news
title: "Seismic Therapeutic pledges new era of immunology drug development with machine learning"
excerpt: "Seismic Therapeutic, Inc., a biotechnology company advancing machine learning for immunology drug development, has announced its launch and $101m in Series A financing. Seismic Therapeutic is accelerating a pipeline of biologics targeting dysregulated ..."
publishedDateTime: 2022-02-14T15:22:00Z
originalUrl: "https://www.biopharma-reporter.com/Article/2022/02/14/Seismic-Therapeutic-immunology-drug-development-with-machine-learning?aca_news_section=Global+Industry+News"
webUrl: "https://www.biopharma-reporter.com/Article/2022/02/14/Seismic-Therapeutic-immunology-drug-development-with-machine-learning?aca_news_section=Global+Industry+News"
type: article
quality: 30
heat: 30
published: false

provider:
  name: biopharma-reporter
  domain: biopharma-reporter.com

topics:
  - Machine Learning
  - AI

images:
  - url: "https://www.biopharma-reporter.com/var/wrbm_gb_food_pharma/storage/images/publications/pharmaceutical-science/biopharma-reporter.com/article/2022/02/14/seismic-therapeutic-immunology-drug-development-with-machine-learning/13239385-2-eng-GB/Seismic-Therapeutic-immunology-drug-development-with-machine-learning.jpg"
    width: 683
    height: 512
    isCached: true

secured: "Xl6tDf1Mo5XMaUMoxFX41b2w2UIvOtHOkdf3TG/k+ti5r496W7PeptlhmilPajJOjRMyX85x7QTMEa3+8Mp/6EPF0kOVnOerl/9whZdJ2IOXeeVL5nac9JlEBTA/qP1lxLEFFnS2KJieo5847H6aztL2NZmrs0LofOun9HX9JBpOJ57/IJPkLPA5GF+I6YVNhlMTJb1QxPBZf7NgQq3xXwsDw6pOE+YEeAPQQcXr/76+bKrOWnBqhcq9K46yQG5wexBSxyUbFZMyRauXD7h3nidsKxdfiIoQUUnyyznhFfzElkV8XYAs00cx2snAjtme+FlI34rwO3A4AoUj1EGBy9hMS6y8g6j22W3chcvEb1w=;K5NvZuze2Fjyc6aZ11KkSQ=="
---

